subscribe
 

Phase 1 bioavailability study initiated

Ablynx initiates Phase 1 of bioavailability study with subcutaneous formulation of its anti-IL-6R Nanobody

Making Pharmaceuticals event driving the industry forwards

From April 29-30, Making Pharmaceuticals event takes place in Birmingham, UK

Advance in protecting mice from acid-mediated cholestatic liver injury

Lead compound in cholestatic liver diseases, A4250, protects against bile acid-mediated cholestatic liver injury in mice

Developing anti-cancer drugs from medicinal plants

Interdisciplinary team that will study medicinal plants incorporating advances in chemistry, nanotechnology, and anti-cancer studies

Using Lego-like DNA to create simple and low cost drug discovery and diagnostic tools

Scientists at the University of Southampton have helped to develop artificial membrane pores, using Lego-like DNA building blocks, which...

Novozymes Biopharma announces collaboration with Almac

Novozymes Biopharma is delighted to announce its new collaboration with Almac, to provide a combined service for drug development...

Nanion Introduces New Product Family: CardioExcyte 96 for Cardiac Toxicity Profiling and Screening

The CardioExcyte 96 is a high resolution device recording contractility in intact cardiomyocyte networks utilizing non-invasive impedance...

New study discovers copper destroys highly infectious norovirus

Worldwide, norovirus is responsible for more than 267 million cases of acute gastroenteritis every year. Scientists have now discovered that...

Novartis receives EU approval for Ilaris®

Novartis receives EU approval for Ilaris® in active Systemic Juvenile Idiopathic Arthritis, a serious form of childhood arthritis

Neutron studies of HIV inhibitors

Neutron studies of HIV inhibitors reveal new areas for improvement in drug design to enhance performance, combat resistance and reduce...

Teaching old drugs new tricks

Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new...

ELRIG Drug Discovery 2013

Students, graduates and post-docs are welcome to compete for the SLAS Young Scientist Award at the ELRIG Drug Discovery 2013 Annual...

Dolomite expertise brings microfluidic product to market

Fledgling spin-out company Drop-Tech has turned to microfluidics specialist Dolomite for its product development and fabrication skills to...

SAW Instruments enhances protein interaction analysis with the sam®X acoustic biosensor

SAW Instruments, developer of the innovative sam® family of biosensors for real-time, label-free biomolecular interaction assays, is...

Training course in preparing stable lyophilized protein formulations

SP Scientific has announced a new hands-on training course entitled 'Rapid and Rational Development of Stable Lyophilized Protein...

World leading scientists join forces to fight devastating degenerative disease

More than 200 international scientists and clinicians who are fighting to find a cure for the devastating degenerative condition Motor...

A fresh approach to developing chronic pain therapeutics

Cellectricon will present a novel phenotypic assay at World Pharma Congress 2013, Tues 4th June, 5pm

Copper destroys norovirus

New research from the University of Southampton shows that copper and copper alloys will rapidly destroy norovirus - the highly-infectious...

Scientists develop worm EEG to test the effects of drugs

Scientists from the University of Southampton have developed a device which records the brain activity of worms to help test the effects of...

Novozymes Biopharma’s recombinant human albumin helps innovative dry eye therapy move into clinical trials

Novozymes Biopharma, part of Novozymes A/S world leader in bioinnovation, has announced that an ophthalmic solution made using its...

Pages

Newsbrief

Twitter Icon © Setform Limited
subscribe